General Information
Version
6.6
Revision date
2024-07-02
Product name
Ozone Test Method: photometric, DPD 0.010
REACH No
This
Icons in SDS
Company Information
company name
Merck Pty Ltd
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Eye irritation, (Category 2) H319: Causes serious eye irritation. Reproductive toxicity, (Category H360FD: May damage fertility. May 1B) damage the unborn child. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure if Thyroid swallowed. 2.2
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H319 Causes serious eye irritation. H360FD May damage fertility. May damage the unborn child. H373 May cause damage to organs (Thyroid) through prolonged or repeated exposure if swallowed. Reduced Labeling (<= 125 ml) H360FD May damage fertility. May damage the unborn child. 2.3
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapors. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. SECTION 3: Composition/information on ingredients Refer to component SDS